Foldax is engages in synthetic heart valve development to deliver non-thrombogenic aortic and mitral valves at dramatically lower cost. Founded in 2013, Foldax is backed by investors that include Caltech – California Institute of Technology, Kairos Ventures, MemorialCare Innovation Fund, BioStar Ventures, and Sayan Bioventures and is headquartered in Salt Lake City.
FOUNDED:
2013
INDUSTRY:
Developer Platform, Manufacturing, Medical Device
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
